Case Control Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 28, 2025; 31(12): 99846
Published online Mar 28, 2025. doi: 10.3748/wjg.v31.i12.99846
Table 1 Clinical characteristics of the two groups, n (%)

Normal LES-IRP group (n = 71)
Increased LES-IRP group (n = 410)
P value
Sex, male/female (n)37/34172/2380.111
Age, median (Q1-Q3) (years)45.0 (35.0-57.0)43.0 (33.0-54.0)0.134
BMI, median (Q1-Q3) (kg/m2)21.5 (19.1-23.8)20.9 (19.2-23.7)0.543
Duration of symptoms,
median (Q1-Q3) (months)
72.0 (24.0-180.0)36.0 (24.0-84.0)0.006
Previous treatment21 (29.5)59 (14.4)0.002
    Balloon dilation10 (14.1)30 (7.3)
    Botox injection2 (2.8)16 (3.9)
    Temporary stenting1 (1.4)6 (1.5)
    Heller myotomy4 (5.6)2 (0.5)
    POEM1 (1.4)2 (0.5)
    Balloon dilation + botox injection1 (1.4)2 (0.5)
    Balloon dilation + temporary stenting2 (2.8)1 (0.2)
Pre-treatment HRM
    LES basal pressure, median (Q1-Q3) (mmHg)14.8 (12.0-20.3)32.3 (23.7-41.8)0.000
    LES-IRP, median (Q1-Q3) (mmHg)11.4 (9.2-12.5)25.7 (20.3-32.3)0.000
Ling classification0.014
    Type Ling I7 (9.9)84 (20.5)
    Type Ling IIa21 (29.6)142 (34.6)
    Type Ling IIb17 (23.9)105 (25.6)
    Type Ling IIc22 (31.0)66 (16.1)
    Type Ling III4 (5.6)13 (3.2)